Acquired risk factors for venous thromboembolism in medical patients

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 1-2, 2006, Pages

  Prandoni, Paolo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Anticoagulation; Deep vein thrombosis; Heparin; Pulmonary embolism; Risk factors; Thrombophilia; Venous thromboembolism; Venous thrombosis; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; D DIMER;

ACUTE DISEASE; AMBULATORY CARE; ATHEROSCLEROSIS; AWARENESS; CANCER; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DEHYDRATION; DEMOGRAPHY; DISEASE ASSOCIATION; ENTERITIS; HOSPITALIZATION; HUMAN; IMMOBILIZATION; INCIDENCE; INFECTION; NEPHROTIC SYNDROME; PARALYSIS; POSTOPERATIVE PERIOD; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM; RHEUMATOID ARTHRITIS; RISK FACTOR; STROKE; VARICOSIS; VENOUS THROMBOEMBOLISM;

ATHEROSCLEROSIS; HUMANS; INFLAMMATION; NEOPLASMS; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; TRAVEL; VENOUS THROMBOSIS;

EID: 33748443071     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107(Suppl. I):9-16.
2. Anderson FA, Wheeler HB. Physicians practices in the management of venous thromboembolism: a community-wide survey. J Vasc Surg 1992;16:707-14.
3. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin Hematol 1997;34:171-87.
4. Nordstrom M, Lindblad B, Berqvist D, Kjelstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-60.
5. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med 1997;157:1665-70.
6. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ 3rd. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002;162:1245-8.
7. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107(Suppl. I):4-8.
8. Prandoni P, Falanga A, Piccioli A. Cancer and venous thromboembolism. Lancet Oncology May 2005;6:401-10.
9. Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from a frontline survey. The Oncologist 2003;8:381-
10. Levitan N, Dowlati A, Remick SC,Tahsildar HI, Sivinski LD, Beyth R, Rimm AA. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 1999;78:285-91.
11. Otten HM, Prins MH. Venous thromboembolism and occult malignancy. Tromb Res 2001;102:V187-94.
12. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293:715-22.
13. Khorana AA, Francis CW, Culakova E, Lyman GH. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005;104:2822-9.
14. Sorensen HT, Mellemkjaer L, Steffensen H, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep-venous thrombosis or pulmonary embolism. N Engl J Med 1998;338:1169-73.
15. Baron JA, Gridley G, Weiderpass E, Nyren G, Linet M. Venous thromboembolism and cancer. Lancet 1998;351:1077-80.
16. Murchison JT, Wylie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br J Cancer 2004;91:92-5.
17. White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, Wun T. Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 2005;165:1782-7.
18. Sorensen HT, Pedersen L, Mellemkjaer L, Johnsen SP, Skriver MV, Olsen JH, Baron JA. The risk of a second cancer after hospitalisation for venous thromboembolism. Br J Cancer 2005;93:838-41.
19. Bura A, Cailleux N, Bienvenu B, Leger P, Bissery A, Boccalon H, Fiessinger JN, Levesque H, Emmerich J. Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost 2004;2:441-4.
20. Schutgens RE, Beckers MM, Haas FJ, Biesma DH. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis. Haematologica 2005;90:214-9.
21. Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G, Sottile A, Naldini L, Comoglio PM. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 2005;434:396-400.
22. Samama M, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793-800.
23. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874-9.
24. Cohen AT, Gallus AS, Lassen MR. Fondaparinux vs placebo for the prevention of venous thromboembolism in acutely ill medical patients. Br Med J (in press).
25. Goldhaber SZ, Tapson VF. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 2004;93:259-62.
26. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 2004;164:963-8.
27. Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2004;2:2156-61.
28. Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005;93:76-9.
29. Chopard P, Dorffler-Melly J, Hess U, Wuillemin WA, Hayoz D, Gallino A, Bachli EB, Canova CR, Isenegger J, Rubino R, Bounameaux H. Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med 2005;257:352-7.
30. Kucher N, Koo S, Quiroz R, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352:969-77.
31. Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, Simioni P, Girolami A. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med. 1994;154:164-8.
32. Samama MM, for the Sirius Study Group. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients. Arch Intern Med 2000;160:3415-20.
33. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997;277:642-5.
34. Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L. Smoking and abdominal obesity. Risk factors for venous thromboembolism among middle-aged men: "The study of men born in 1913". Arch Intern Med 1999; 159:1886-90.
35. Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 2005;48:1017-21.
36. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med 2005; 18:978-80.
37. van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002;116:173-7.
38. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR. Coagulation factors, inflammation markers, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Am J Med 2002;113:636-42.
39. Andreescu ACM, Cushman M, Rosendaal FR. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study. Thromb Haemost 2002;87:42-51.
40. Cushman M, Folsom AR, Wang L, Aleksic N, Rosamond WD, Tracy RP, Heckbert SR. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003;101:1243-8.
41. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AWA, Prins MH, Girolami A. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-41.
42. Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, Poggio R, Imberti D, Ageno W, Pogliani E, Porro F, Casazza F. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005;26:77-83.